about
Potential role of a new PEGylated recombinant factor VIII for hemophilia A.Different impact of factor VIII products on inhibitor development?Antidrug Antibodies: B Cell Immunity Against TherapyThe current state of adverse event reporting in hemophilia.The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.Registry-based outcome assessment in haemophilia: a scoping study to explore the available evidence.Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells.Gene therapy for immune tolerance induction in hemophilia with inhibitors.Haemophilia treatment in 2030.A close insight to factor VIII inhibitor in the congenital hemophilia A.2017 Clinical trials update: Innovations in hemophilia therapy.Incidence of low-titre factor VIII inhibitors in patients with haemophilia A: meta-analysis of observational studies.T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.A prevalent CTLA4 missense variant significantly associates with inhibitor development in Argentine patients with severe haemophilia A.Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A.Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.
P2860
Q26744309-F5B51DAF-245C-49B8-9BF4-78B901764717Q28075679-C6FDBB66-5F97-42A9-ACD0-58D8091CE8A9Q28082303-7AAF3EDE-5F9A-431F-B0CF-56565E319587Q30239952-A70293D8-D411-4FC4-8DCE-7AAEDA1F9117Q38748723-68A4E679-8DEB-4AED-9CAD-A602F876AFC8Q38783210-98D9A5D7-91A3-487F-B6A9-917B288F1CE0Q38792889-AAD5408C-1138-4767-9CB8-237273B2271CQ38803022-C00567CD-DA43-4BA6-A93B-DDDD7A208EBDQ38842671-34413B49-582D-489E-BA47-F47900BCD115Q38883211-075AF04C-6027-4B67-9F7E-78581172CFE5Q38937725-8642143F-E075-4BE6-AB8D-0FF8530B011EQ38950767-1F6E2CBC-4370-4C2E-BB6B-AC5F8C0E9F66Q42381250-48DF1B2D-8212-43B1-BA39-0BD1AC660243Q45864974-9258BC0E-68C0-472F-B624-52955BC478C9Q45875675-8892F4BD-5D36-483C-B161-6BF357575E73Q45875860-E63E6D58-2F04-470A-8DDF-4468F8704AC6
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
FVIII inhibitors: pathogenesis and avoidance
@ast
FVIII inhibitors: pathogenesis and avoidance
@en
FVIII inhibitors: pathogenesis and avoidance
@nl
type
label
FVIII inhibitors: pathogenesis and avoidance
@ast
FVIII inhibitors: pathogenesis and avoidance
@en
FVIII inhibitors: pathogenesis and avoidance
@nl
prefLabel
FVIII inhibitors: pathogenesis and avoidance
@ast
FVIII inhibitors: pathogenesis and avoidance
@en
FVIII inhibitors: pathogenesis and avoidance
@nl
P2860
P3181
P1433
P1476
FVIII inhibitors: pathogenesis and avoidance
@en
P2093
J. Astermark
P2860
P304
P3181
P356
10.1182/BLOOD-2014-08-535328
P407
P577
2015-03-26T00:00:00Z